§ 13F · FUND PROFILE
General Catalyst Group Management, LLC.
AUM · $189M (13F)Positions · 14Turnover · n/a · Q2Filed · Aug 17, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | AVBP | ArriVent BioPharma, Inc. | 1.49M | $52M | — | — |
| 2 | PBLS | Parabilis Medicines, Inc. | 1.60M | $44M | — | — |
| 3 | CART | Maplebear, Inc. | 711K | $34M | — | — |
| 4 | MAZE | Maze Therapeutics, Inc. | 1.04M | $31M | — | — |
| 5 | ODTX | Odyssey Therapeutics, Inc. | 810K | $15M | — | — |
| 6 | EIKN | Eikon Therapeutics, Inc. | 305K | $4M | — | — |
| 7 | GUTS | Fractyl Health, Inc. | 4.88M | $4M | — | — |
| 8 | LIFE | Ethos Technologies, Inc. | 74K | $1M | — | — |
| 9 | CPNG | Coupang Inc. | 55K | $950K | — | — |
| 10 | AMZN | Amazon.com Inc. | 4K | $925K | — | — |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE GENERAL SIGNAL
AC read
General Catalyst Group Management, LLC is a Other fund managing $189 million in assets. The fund runs a focused portfolio of just 14 positions.
Read the full dossier →